Home Cart Sign in  
Chemical Structure| 1809336-93-3 Chemical Structure| 1809336-93-3

Structure of Valemetostat tosylate
CAS No.: 1809336-93-3

Chemical Structure| 1809336-93-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Valemetostat tosylate (DS-3201 tosylate) is a novel inhibitor of enhancer of zeste homolog 1 and 2 (EZH1/2) with an IC50 of <10 nM. It can be used in the research of relapsed and refractory peripheral T-cell lymphoma.

Synonyms: DS-3201 tosylate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Valemetostat tosylate

CAS No. :1809336-93-3
Formula : C33H42ClN3O7S
M.W : 660.22
SMILES Code : O=C(C1=CC(Cl)=C(O[C@](C)([C@H]2CC[C@H](N(C)C)CC2)O3)C3=C1C)NCC4=C(C)C=C(C)NC4=O.O=S(C5=CC=C(C)C=C5)(O)=O
Synonyms :
DS-3201 tosylate
MDL No. :MFCD32197179
InChI Key :JSBKGJUYSLVFPF-RRKMXGHKSA-N
Pubchem ID :126482037

Safety of Valemetostat tosylate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Valemetostat tosylate

epigenetics

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT04842877 Lymphoma, B-Cell PHASE2 ACTIVE_NOT_RECRUITING 2025-10-26 A.Z. Sint Jan AV, Bruges, 8000... More >>, Belgium|University Hospital Gent, Gent, 9000, Belgium|CH Tourelle Peltzer, Verviers, 4800, Belgium|CHU Mont-Godinne, Yvoir, Belgium|CH d'Avignon, Avignon, 84000, France|CH de la C?te Basque, Bayonne, 64109, France|Institut Bergonié, Bordeaux, 33076, France|Institut d'Hématologie de Basse Normandie, Caen, 14076, France|Ch Metropole Savoie - Site Chambery, Chambéry, 73000, France|CHU d'Estaing, Clermont-Ferrand, 63000, France|Fran?ois Lemonnier, Créteil, 94010, France|CHU de Dijon, Dijon, 21034, France|Chd de Vendee, La Roche-sur-Yon, 85925, France|Clinique Victor Hugo, Le Mans, 72000, France|Service des Maladies du Sang - CHRU de Lille, Lille, 59037, France|Institut Paoli Calmette, Marseille, 13273, France|CHU de Montpellier, Montpellier, 34295, France|Gh Region Mulhouse Et Sud Alsace, Mulhouse, 68070, France|CHU H?tel Dieu, Nantes, 44093, France|Emmanuel Bachy, Pierre Bénite, 69495, France|CHU Pontchaillou, Rennes, 35003, France|Ch de Bretagne Atlantique -, Vannes, 56017, France Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.51mL

0.30mL

0.15mL

7.57mL

1.51mL

0.76mL

15.15mL

3.03mL

1.51mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories